Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Klingberg

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|December 28, 2020
Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline StructuresAnika Alberts, Annika Klingberg, Leonie Hoffmeister, et al.
Thrombosis and Haemostasis|February 3, 2026
Pharmacodynamic interaction between emicizumab and coagulation Factor VIIIMatthias Chill, Emma Louise Konarski, Annika Klingberg, et al.
Scientific Reports|March 17, 2022
Natural antibodies and CRP drive anaphylatoxin production by urate crystalsAnne Kathrin Wessig, Leonie Hoffmeister, Annika Klingberg, et al.
Scientific Reports|April 15, 2020
C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1Anika Alberts, Annika Klingberg, Anne Kathrin Wessig, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2026
Transfer of Emicizumab into Breast Milk in Postpartum Acquired Hemophilia ASimon Alexander Krooss, Tim Halling, Dirk Varnholt, et al.
Blood Advances|August 10, 2022
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 studyOlga Oleshko, Sonja Werwitzke, Annika Klingberg, et al.
Haematologica|November 13, 2025
Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxisFabius J Pelzer, Ella I Ertekin, Olga Oleshko, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|December 28, 2020
Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline StructuresAnika Alberts, Annika Klingberg, Leonie Hoffmeister, et al.
Thrombosis and Haemostasis|February 3, 2026
Pharmacodynamic interaction between emicizumab and coagulation Factor VIIIMatthias Chill, Emma Louise Konarski, Annika Klingberg, et al.
Scientific Reports|March 17, 2022
Natural antibodies and CRP drive anaphylatoxin production by urate crystalsAnne Kathrin Wessig, Leonie Hoffmeister, Annika Klingberg, et al.
Scientific Reports|April 15, 2020
C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1Anika Alberts, Annika Klingberg, Anne Kathrin Wessig, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2026
Transfer of Emicizumab into Breast Milk in Postpartum Acquired Hemophilia ASimon Alexander Krooss, Tim Halling, Dirk Varnholt, et al.
Blood Advances|August 10, 2022
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 studyOlga Oleshko, Sonja Werwitzke, Annika Klingberg, et al.
Haematologica|November 13, 2025
Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxisFabius J Pelzer, Ella I Ertekin, Olga Oleshko, et al.
Pageof 1